Wed, September 13, 2023
Tue, September 12, 2023
Mon, September 11, 2023
Fri, September 8, 2023
Thu, September 7, 2023
Wed, September 6, 2023

Joseph Schwartz Upgraded (SPRB) to Buy and Increased Target to $9 on, Sep 8th, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. y-and-increased-target-to-9-on-sep-8th-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Joseph Schwartz of SVB Leerink, Upgraded "Spruce Biosciences, Inc." (SPRB) to Buy and Increased Target from $3 to $9 on, Sep 8th, 2023.

Joseph has made no other calls on SPRB in the last 4 months.



There are 5 other peers that have a rating on SPRB. Out of the 5 peers that are also analyzing SPRB, 0 agree with Joseph's Rating of Hold.



These are the ratings of the 5 analyists that currently disagree with Joseph


  • Hartaj Singh of "Oppenheimer" Maintained at Buy with Decreased Target to $7 on, Friday, August 18th, 2023
  • Raghuram Selvaraju of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $10 on, Friday, August 18th, 2023
  • Jonathan Wolleben of "JMP Securities" Maintained at Buy with Increased Target to $8 on, Wednesday, August 16th, 2023
  • Gregory Renza of "RBC Capital" Reiterated at Buy and Held Target at $8 on, Tuesday, August 15th, 2023
  • Tiago Fauth of "Credit Suisse" Reiterated at Buy and Held Target at $4 on, Tuesday, May 16th, 2023

Publication Contributing Sources